Blog Archives

Ya-Lin (Amber) Chen earned her PharmD and Master’s degree in biomedical informatics at Taipei Medical University. During her Master’s program, she published the first machine learning study on medication adherence in Taiwan, focusing on insulin usage for type 2 diabetes patients. In addition to academic achievements, she contributed to the practical aspects of healthcare by working as a community pharmacist. She also gained experience in a medical software startup, creating safety solutions for medication errors. Amber is a Fulbright grantee from 2022 to 2024 to pursue doctoral education at the University of Washington. Currently, her research focus includes survival analysis, survival prediction, and fatty liver disease.